Where does Xenios AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Xenios AG ranks #19,361 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Xenios AG hold?

Xenios AG holds 15 US utility patents granted between 2019 and 2025, spanning 10 technology areas.

What is Xenios AG's Innovation Score?

Xenios AG has an Innovation Score of 38.2 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Xenios AG's patent grant rate increasing or decreasing?

Xenios AG's recent grant velocity is +500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Xenios AG's patents?

Xenios AG's patents average 14.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Xenios AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Xenios AG

Q: What technology areas does Xenios AG focus on?

Xenios AG's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 12 patents, ranking #592 of 3,490 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 15 granted patents across 10 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Xenios ranks #19,361 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 10 technology areas.

#19,361
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.2/100): 14.2
avg claims per patent: +500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19361 · Foreign Corporation #19,361 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #19,361/49,997
PHOTO-FINISH Xeikon IP B V
CPC-FOCUS A61M · 10 areas
INNOV-THIN 38.2/100
CLAIMS-RICH 14.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Xeikon IP B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Xenios’s 38.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (25%) Velocity 8.9 pts (23%) Breadth 11.2 pts (29%) Claim depth 8.5 pts (22%)

Qualcomm Incorporated · highest

85
Xenios · this assignee

38
3D Lighting… · lowest

7

What this shows Xenios's Innovation Score is 38.2/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Xenios?

Each dot is one of Xenios’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Xenios’s own 14.2 claims/patent is ABOVE the 8.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Xenios vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Xenios's grants concentrate

Xenios AG is a focused PatentsView assignee: 10 CPC subclasses with 80% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2022 (5 grants) versus a trough of 2 in 2019. By volume, Xenios sits between Xela Innovations, LLC and Xinjiang Technical Institute of Physics and Chimestry, Chinese Academy of Sciences.

Xenios's three-year grant acceleration

Xenios AG shows 8 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Xela Innovations

15
Xenith

15
Xeikon IP B V

15
Xeltis

15
Xiamen Forbetter…

15
Xiamen Retone Hea…

15
Xinadda (Hong Kon…

15
Xinjiang Technica…

15
Xenios ◀

15

What this shows Xenios holds 15 patents at rank #19,357, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Xenios

By rank, the assignees closest to #19,357 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Xenios's primary technology class.

Xenios's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Xenios AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	13.3%
2020	4	26.7%
2022	5	33.3%
2023	3	20.0%
2025partial year	1	6.7%

Which technologies does Xenios AG patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 12

B01D - Separation 2

A61B - DIAGNOSIS; SURGERY; Identification 2

F16L - PIPES; Joints OR Fittings FOR PIPES; Supports FOR Pipes, Cables OR Protective TUBING; Means FOR Thermal Insulation IN General 2

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

B60R - Vehicles, Vehicle Fittings, OR Vehicle Parts, NOT Otherwise Provided FOR 1

A47G - Household OR Table Equipment 1

B25B - Tools OR Bench Devices NOT Otherwise Provided FOR, FOR Fastening, Connecting, Disengaging OR Holding 1

H02G - Installation OF Electric Cables OR Lines, OR OF Combined Optical AND Electric Cables OR Lines 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Xenios AG's patent record in context - here's where to go next.

Xenios AG's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 80% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #19,361 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Xenios AG against Xela Innovations, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.